December 14, 2016 / 1:10 PM / 7 months ago

BRIEF-Alcobra updates on recent FDA meeting

1 Min Read

Dec 14 (Reuters) - Alcobra Ltd -

* Expects to provide further details regarding MDX regulatory path upon receipt of final meeting minutes from dpp in coming weeks

* Alcobra updates on recent FDA meeting

* Held meeting with division of u.s. Fda to discuss their decision to place full clinical hold on development programs of MDX, paths to resume trials Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below